We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$51B
AUM Growth
+$4.88B
Cap. Flow
+$834M
Cap. Flow %
1.63%
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39

Top Buys

Rank Stock Value
1
KSPI icon
Kaspi.kz JSC
KSPI
+$260M
2
MSFT icon
Microsoft
MSFT
+$71.2M
3
CAH icon
Cardinal Health
CAH
+$61.4M
4
CLX icon
Clorox
CLX
+$47.7M
5
ACN icon
Accenture
ACN
+$46.1M

Sector Composition

Rank Sector Weight
1 Technology 28.39%
2 Healthcare 17.34%
3 Financials 11.02%
4 Consumer Discretionary 9.2%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTHT icon
726
Huazhu Hotels Group
HTHT
$12.8B
$3.31M 0.01%
85,494
-3,632
-4% -$126K
ONC
727
BeOne Medicines Ltd
ONC
$32.2B
$3.31M 0.01%
21,138
ADPT icon
728
Adaptive Biotechnologies
ADPT
$3.5B
$3.3M 0.01%
1,029,447
+95,653
+10% +$370K
RNAM
729
DELISTED
Avidity Biosciences
RNAM
$3.3M 0.01%
129,414
IHS icon
730
IHS Holding
IHS
$2.75B
$3.24M 0.01%
916,700
+471,817
+106% +$1.61M
RLYB icon
731
Rallybio
RLYB
$88.7M
$3.2M 0.01%
215,883
PATH icon
732
UiPath
PATH
$6.3B
$3.19M 0.01%
140,824
+3,820
+3% +$89.4K
NDSN icon
733
Nordson
NDSN
$15.9B
$3.17M 0.01%
11,563
-139
-1% -$36.2K
GEO icon
734
The GEO Group
GEO
$4.09B
$3.14M 0.01%
222,700
LEA icon
735
Lear
LEA
$7.02B
$3.12M 0.01%
21,566
-866
-4% -$119K
GNRC icon
736
Generac Holdings
GNRC
$12.6B
$3.09M 0.01%
24,487
-376
-2% -$44.1K
PYXS icon
737
Pyxis Oncology
PYXS
$143M
$3.02M 0.01%
708,303
ALV icon
738
Autoliv
ALV
$8.58B
$3.01M 0.01%
24,968
-65
-0.3% -$7.27K
SRRK icon
739
Scholar Rock
SRRK
$6.07B
$3M 0.01%
168,997
BIO icon
740
Bio-Rad Laboratories Class A
BIO
$8.08B
$3M 0.01%
8,663
-129
-1% -$42.4K
HEI icon
741
HEICO Corp
HEI
$47.6B
$2.95M 0.01%
15,453
-46
-0.3% -$8.54K
TME icon
742
Tencent Music
TME
$15B
$2.86M 0.01%
255,276
-831
-0.3% -$8.15K
MIRM icon
743
Mirum Pharmaceuticals
MIRM
$7.11B
$2.76M 0.01%
+109,758
New +$3.02M
AES icon
744
AES
AES
$10.6B
$2.73M 0.01%
152,049
-4,281
-3% -$71.5K
U icon
745
Unity
U
$13B
$2.72M 0.01%
101,743
+1,816
+2% +$57.1K
MREO
746
Mereo BioPharma
MREO
$48.7M
$2.7M 0.01%
817,309
-733,773
-47% -$2.48M
SEIC icon
747
SEI Investments
SEIC
$12B
$2.69M 0.01%
37,422
+499
+1% +$33.1K
LUV icon
748
Southwest Airlines
LUV
$23.6B
$2.68M 0.01%
91,927
-3,984
-4% -$123K
TARS icon
749
Tarsus Pharmaceuticals
TARS
$2.45B
$2.62M 0.01%
72,032
Z icon
750
Zillow
Z
$7.56B
$2.59M 0.01%
53,039
-149
-0.3% -$8.11K

Similar funds

Aberdeen Group's Q1 2024 Portfolio in Review

As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
  • Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
  • Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
  • Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
  • Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
  • Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
  • Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.

Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.